Colorectal Cancer Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Colorectal Cancer Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason.

The size of these pipelines ranges from 10 products in rectal cancer to 581 products in colorectal cancer. Across all three of these indications, however, kinases, immune-related proteins, DNA-related proteins and viral proteins are common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Colorectal Cancer Report Coverage 11
2.2 Anal Cancer - Overview 11
2.3 Rectal Cancer - Overview 11
2.4 Colorectal Cancer - Overview 11
3 Therapeutics Development 12
3.1 Anal Cancer 12
3.2 Rectal Cancer 16
3.3 Colorectal Cancer 18
4 Therapeutics Assessment 56
4.1 Anal Cancer 56
4.2 Rectal Cancer 63
4.3 Colorectal Cancer 71
5 Companies Involved in Therapeutics Development 100
5.1 Anal Cancer 100
5.2 Rectal Cancer 108
5.3 Colorectal Cancer 114
6 Dormant Projects 241
6.1 Anal Cancer 241
6.2 Rectal Cancer 241
6.3 Colorectal Cancer 242
7 Discontinued Products 261
7.1 Anal Cancer 261
7.2 Colorectal Cancer 261
8 Product Development Milestones 265
8.1 Anal Cancer 265
8.2 Rectal Cancer 278
8.3 Colorectal Cancer 280
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/colorectal-cancer-therapeutics-strategies-and-product-pipeline-review-2017/250073

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250073

More News From marketerslog.com

US stock indexes step back after a big gain; retailers climb

Nov 19, 2017

NEW YORK — U.S. stock indexes are mostly lower Friday, as technology companies decline a day after the market's biggest gain in two months. Retailers including Ross Stores, Gap and Foot Locker are jumping after they reported strong quarterly results. Smaller companies are also rising. KEEPING SCORE: The Standard & Poor's 500 index fell 4 points, or 0.2 percent, to 2,580 as of 3:15 p.m. Eastern time. The Dow Jones industrial average gave up 85 points, or 0.4 percent, to 23,372. The Nasdaq composite dipped 9 points, or 0.1 percent, to 6,784 after it closed at a record high Thursday....

Strong earnings from Wal-Mart, Cisco drive US stocks higher

Nov 19, 2017

U.S. stocks closed sharply higher Thursday, snapping a two-day losing streak. Investors cheered strong quarterly earnings from Wal-Mart Stores, Cisco Systems and other companies. Technology stocks accounted for much of the market's gains, which helped lift the Nasdaq composite to its first record high in just over a week. Health care companies and consumer product makers also posted solid gains. Energy and utilities stocks lagged. Oil prices declined. The rally knocked the major stock indexes into positive territory for the month, as investors seized on the encouraging company earnings news to buy shares a day after the market suffered its...

Paraguay judge approves extradition of soccer official Leoz

Nov 19, 2017

ASUNCION, Paraguay — A judge in Paraguay approved the extradition of Nicolas Leoz, the former president of South America's soccer confederation, on Thursday. The 89-year-old Leoz is charged in a corruption scandal being investigated by the U.S. Justice Department. For decades, Leoz was practically untouchable despite corruption allegations. But he has been held under house arrest in the Paraguayan capital fighting the extradition order to the U.S., where he has been wanted since 2015 on charges of receiving millions of dollars in bribes from marketing companies in exchange for TV and marketing rights to soccer tournaments. "The court has finally...

Global stocks higher, oil prices steady

Nov 19, 2017

SEOUL, South Korea — Global shares rose Thursday while oil prices were steady. Analysts said that despite the rebound it was too early to say risk sentiment was back. Apart from persisting worries over prospects for a U.S. tax overhaul and doubts over the pace of rate hikes by the Federal Reserve, market-moving news was scarce. KEEPING SCORE: Britain's FTSE 100 opened nearly unchanged at 7,369.96. France's CAC 40 rose 0.5 percent to 5,325.55 and Germany's DAX gained 0.5 percent to 13,045.32. Futures augured modest gains on Wall Street. S&P futures rose 0.3 percent while Dow futures added 0.2 percent....

Asian stocks, oil prices steady

Nov 19, 2017

SEOUL, South Korea — Asian stock markets were mostly firm on Thursday and oil prices were steady, despite a second straight day of losses on Wall Street overnight. But analysts said it was too early to say risk sentiment was back after a day of heavy losses in Asia. Other than on-going worries about the prospect of the U.S. tax reform plan and the pace of the Federal Reserve's rate hike, there were little market-moving headlines. KEEPING SCORE: Japan's Nikkei 225 rose 0.8 percent to 22,210.45 and South Korea's Kospi advanced 0.5 percent to 2,531.74. Hong Kong's Hang Seng index...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH